Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

Name: Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression
SKU: 24335
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 51 No. 3 Articles 2021 Tags: Aalim Weljie, Anup Sharma, Arjun Sengupta, depression, hiv, insomnia, Jennifer R. Goldschmied, Knashawn H. Morales, Lynne Taylor, Matthew S. Kayser, metabolomics, michael-e-thase, zaleplon

Description

Description

Original Research

Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

By Jennifer R. Goldschmied, Arjun Sengupta, Anup Sharma, Lynne Taylor, Knashawn H. Morales, Michael E. Thase, Aalim Weljie, and Matthew S. Kayser

Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

Description

Original Research

Depression Rating Scales – A Doctor’s Guide

Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine

Strategies for Treatment-Resistant Depression

Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

Description

Original Research

Related products

Depression Rating Scales – A Doctor’s Guide

Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine

Strategies for Treatment-Resistant Depression